Impacts of Habitual Diets Intake on Gut Microbial Counts in Healthy Japanese Adults.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
12 Aug 2020
Historique:
received: 08 07 2020
revised: 03 08 2020
accepted: 04 08 2020
entrez: 19 8 2020
pubmed: 19 8 2020
medline: 17 3 2021
Statut: epublish

Résumé

Although diet is an important factor influencing gut microbiota, there are very few studies regarding that relationship in Japanese people. Here, we analyzed the relationship between habitual dietary intake surveyed by food frequency questionnaire and the quantitative features of gut bacteria by quantitative PCR and next generation sequencer in 354 healthy Japanese adults. The α-diversity of gut microbiota was positively correlated with the intake of mushrooms and beans and negatively correlated with the intake of grains. The β-diversity was significantly associated with the intake of fruits, mushrooms, seaweeds, seafoods, and alcoholic beverages. Multiple linear regression analysis of the relationship between food groups associated with the diversity of gut microbiota and the number of gut bacteria at the genus level found 24 significant associations, including a positive association between alcoholic beverages and the number of

Identifiants

pubmed: 32806561
pii: nu12082414
doi: 10.3390/nu12082414
pmc: PMC7468936
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Front Nutr. 2019 Apr 17;6:47
pubmed: 31058160
Gut. 2016 Dec;65(12):1973-1980
pubmed: 26311717
ISME J. 2012 Aug;6(8):1621-4
pubmed: 22402401
Int J Obes (Lond). 2013 Feb;37(2):216-23
pubmed: 22410962
Tissue Barriers. 2017 Oct 2;5(4):e1373208
pubmed: 28956703
Science. 2011 Oct 7;334(6052):105-8
pubmed: 21885731
Anaerobe. 2004 Jun;10(3):197-203
pubmed: 16701519
Hepatology. 2011 Aug;54(2):562-72
pubmed: 21574172
Cancer Res Treat. 2018 Apr;50(2):474-487
pubmed: 28546524
Mar Drugs. 2019 Jun 01;17(6):
pubmed: 31159359
Gut. 2019 Jul;68(7):1335-1337
pubmed: 29934439
Int J Obes (Lond). 2018 Mar;42(3):580-583
pubmed: 28883543
Nat Commun. 2016 Jun 24;7:11939
pubmed: 27340092
PLoS One. 2017 Apr 10;12(4):e0175497
pubmed: 28394924
Microbiome. 2016 Jun 29;4(1):33
pubmed: 27357127
Gut. 2019 Aug;68(8):1417-1429
pubmed: 30782617
Nutrients. 2018 Oct 02;10(10):
pubmed: 30279332
J Epidemiol. 1996 Mar;6(1):45-53
pubmed: 8795957
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Alcohol Res. 2015;37(2):223-36
pubmed: 26695747
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Appl Environ Microbiol. 2006 Jul;72(7):5069-72
pubmed: 16820507
Microorganisms. 2019 Jan 10;7(1):
pubmed: 30634578
Nature. 2014 Jan 23;505(7484):559-63
pubmed: 24336217
Front Nutr. 2018 Apr 12;5:23
pubmed: 29707542
Thyroid Res. 2011 Oct 05;4:14
pubmed: 21975053
Appl Environ Microbiol. 2015 Nov;81(22):7945-56
pubmed: 26386056
Eur J Cancer Prev. 2017 May;26(3):201-211
pubmed: 26945285
Nutrients. 2019 Oct 07;11(10):
pubmed: 31591348
Am J Clin Nutr. 2018 Jun 1;107(6):965-983
pubmed: 29757343
Science. 2016 Apr 29;352(6285):565-9
pubmed: 27126040
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4516-22
pubmed: 20534432
Pharmacol Res. 2013 Mar;69(1):42-51
pubmed: 23089410
Biochem J. 2017 May 16;474(11):1823-1836
pubmed: 28512250
Nature. 2016 Jul 06;535(7610):85-93
pubmed: 27383983
Br J Nutr. 2014 Mar 14;111(5):773-84
pubmed: 24128654
J Nutr Sci Vitaminol (Tokyo). 2017;63(6):396-404
pubmed: 29332901
Am J Physiol Gastrointest Liver Physiol. 2016 Sep 1;311(3):G521-32
pubmed: 27492329
Sci Rep. 2017 May 19;7(1):2167
pubmed: 28526852
Am J Physiol Gastrointest Liver Physiol. 2012 May 1;302(9):G966-78
pubmed: 22241860
PLoS One. 2010 Nov 29;5(11):e15046
pubmed: 21151493
Annu Rev Food Sci Technol. 2018 Mar 25;9:65-84
pubmed: 29298101
Am J Clin Nutr. 2019 May 1;109(5):1472-1483
pubmed: 31051503
Nature. 2017 Nov 23;551(7681):507-511
pubmed: 29143816
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Br J Nutr. 2008 Jan;99(1):110-20
pubmed: 17761020
Nat Microbiol. 2019 Nov;4(11):1826-1831
pubmed: 31209308
Gut. 2015 Jan;64(1):93-100
pubmed: 25016597
Nat Rev Immunol. 2009 May;9(5):313-23
pubmed: 19343057
Science. 2016 Apr 29;352(6285):560-4
pubmed: 27126039
Appl Environ Microbiol. 2004 Dec;70(12):7220-8
pubmed: 15574920
Appl Environ Microbiol. 2010 Aug;76(16):5440-51
pubmed: 20581195
Br J Nutr. 2007 Aug;98(2):364-72
pubmed: 17403273
J Nutr. 2013 Apr;143(4):526-32
pubmed: 23343678
Nat Biotechnol. 2019 Aug;37(8):852-857
pubmed: 31341288
Benef Microbes. 2019 Dec 9;10(8):841-854
pubmed: 31965840

Auteurs

Takuya Sugimoto (T)

Yakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo 186-8650, Japan.

Tatsuichiro Shima (T)

Yakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo 186-8650, Japan.

Ryuta Amamoto (R)

Yakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo 186-8650, Japan.

Chiaki Kaga (C)

Yakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo 186-8650, Japan.

Yukiko Kado (Y)

Yakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo 186-8650, Japan.

Osamu Watanabe (O)

Development Department, Yakult Honsha Co., Ltd., 1-10-30 Kaigan, Minato-ku, Tokyo 105-8660, Japan.

Junko Shiinoki (J)

Development Department, Yakult Honsha Co., Ltd., 1-10-30 Kaigan, Minato-ku, Tokyo 105-8660, Japan.

Kaoru Iwazaki (K)

Corporate Planning Office, Yakult Honsha Co., Ltd., 1-10-30 Kaigan, Minato-ku, Tokyo 105-8660, Japan.

Hiroko Shigemura (H)

Corporate Planning Office, Yakult Honsha Co., Ltd., 1-10-30 Kaigan, Minato-ku, Tokyo 105-8660, Japan.

Hirokazu Tsuji (H)

Yakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo 186-8650, Japan.

Satoshi Matsumoto (S)

Yakult Central Institute, 5-11 Izumi, Kunitachi-shi, Tokyo 186-8650, Japan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH